Thromb Haemost 1980; 43(02): 182
DOI: 10.1055/s-0038-1650045
Letter to the Editor
Schattauer GmbH Stuttgart

Evaluation of Plasminogen and other Fibrinolytic Parameters in the Amniotic Fluid

J Aznar
Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain
,
J Gilabert
Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain
,
A Estelles
Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain
,
J J Parrilla
Department of Clinical Pathology, Department of Obstetrics and Gynecology and Research Center, Ciudad Sanitaria "La Fe". Valencia. Spain
› Author Affiliations
Further Information

Publication History

Received 14 November 1979

Accepted 05 February 1980

Publication Date:
13 July 2018 (online)

 
  • References

  • 1 Aznar J, Hernandez A, Parrilla JJ, Estelles A, Gilabert J. Changes in human amniotic fluid fibrinolytic inhibitors levels during pregnancy. Thrombos Haemost 1976; 35: 382-385
  • 2 Wu KK, Jacobsen CD, Hoak JC. Highly sensitive method for the assay of plasminogen. J Lab Clin Med 1973; 81: 484-488
  • 3 Merskey C, Lalezary P, Johnson AJ. A rapid method for measuring fibrinogen split products in human serum. Proc Soc Exp Biol Med 1969; 131: 871-875
  • 4 Aoki N, von Kaulla RN. Inactivation of human serum plasminogen antiactivator by synthetic fibrinolysis inducers. Thrombos Diath Haemorrh 1969; 22: 251-262
  • 5 Hawkey CM, Stafford JL. A standard clot method for assay of plasminogen activator antiactivators and plasmin. J Clin Pathol 1964; 17: 175-181
  • 6 Phillips LL, Davidson EC. Procoagulant properties of amniotic fluid. Am J Obstet Gynecol 1972; 113: 911-919